225 related articles for article (PubMed ID: 32762830)
21. Endocannabinoids and the Digestive Tract and Bladder in Health and Disease.
Izzo AA; Muccioli GG; Ruggieri MR; Schicho R
Handb Exp Pharmacol; 2015; 231():423-47. PubMed ID: 26408170
[TBL] [Abstract][Full Text] [Related]
22. Cannabis and Endocannabinoid Signaling in Epilepsy.
Katona I
Handb Exp Pharmacol; 2015; 231():285-316. PubMed ID: 26408165
[TBL] [Abstract][Full Text] [Related]
23. Cannabis and Turmeric as Complementary Treatments for IBD and Other Digestive Diseases.
Quezada SM; Cross RK
Curr Gastroenterol Rep; 2019 Jan; 21(2):2. PubMed ID: 30635796
[TBL] [Abstract][Full Text] [Related]
24. Cannabis y los sistemas exocannabinoide y endocannabinoide. Su uso y controversias.
Millán-Guerrero RO; Isais-Millán S
Gac Med Mex; 2019; 155(5):508-512. PubMed ID: 31695229
[TBL] [Abstract][Full Text] [Related]
25. Cannabinoid Receptors in Regulating the GI Tract: Experimental Evidence and Therapeutic Relevance.
Taschler U; Hasenoehrl C; Storr M; Schicho R
Handb Exp Pharmacol; 2017; 239():343-362. PubMed ID: 28161834
[TBL] [Abstract][Full Text] [Related]
26. The Role of the Endocannabinoid System in the Brain-Gut Axis.
Sharkey KA; Wiley JW
Gastroenterology; 2016 Aug; 151(2):252-66. PubMed ID: 27133395
[TBL] [Abstract][Full Text] [Related]
27. Resveratrol attenuates high-fat diet-induced non-alcoholic steatohepatitis by maintaining gut barrier integrity and inhibiting gut inflammation through regulation of the endocannabinoid system.
Chen M; Hou P; Zhou M; Ren Q; Wang X; Huang L; Hui S; Yi L; Mi M
Clin Nutr; 2020 Apr; 39(4):1264-1275. PubMed ID: 31189495
[TBL] [Abstract][Full Text] [Related]
28. Cannabinoids and gastrointestinal motility: animal and human studies.
Aviello G; Romano B; Izzo AA
Eur Rev Med Pharmacol Sci; 2008 Aug; 12 Suppl 1():81-93. PubMed ID: 18924447
[TBL] [Abstract][Full Text] [Related]
29. Cannabinoid CB
Spiller KJ; Bi GH; He Y; Galaj E; Gardner EL; Xi ZX
Br J Pharmacol; 2019 May; 176(9):1268-1281. PubMed ID: 30767215
[TBL] [Abstract][Full Text] [Related]
30. The Important Role of the Endocannabinoid System and the Endocannabinoidome in Gut Health.
Meletis C
Altern Ther Health Med; 2019 Jun; 25(S2):24-28. PubMed ID: 31202201
[TBL] [Abstract][Full Text] [Related]
31. The endocannabinoid system.
Kilaru A; Chapman KD
Essays Biochem; 2020 Sep; 64(3):485-499. PubMed ID: 32648908
[TBL] [Abstract][Full Text] [Related]
32. Inhibiting CB1 receptors improves lipogenesis in an in vitro non-alcoholic fatty liver disease model.
Shi D; Zhan X; Yu X; Jia M; Zhang Y; Yao J; Hu X; Bao Z
Lipids Health Dis; 2014 Nov; 13():173. PubMed ID: 25406988
[TBL] [Abstract][Full Text] [Related]
33. Pro-resolution, protective and anti-nociceptive effects of a cannabis extract in the rat gastrointestinal tract.
Wallace JL; Flannigan KL; McKnight W; Wang L; Ferraz JG; Tuitt D
J Physiol Pharmacol; 2013 Apr; 64(2):167-75. PubMed ID: 23756391
[TBL] [Abstract][Full Text] [Related]
34. Effects of cannabis tetrahydrocannabinol on endocannabinoid homeostasis in human placenta.
Maia J; Midão L; Cunha SC; Almada M; Fonseca BM; Braga J; Gonçalves D; Teixeira N; Correia-da-Silva G
Arch Toxicol; 2019 Mar; 93(3):649-658. PubMed ID: 30659320
[TBL] [Abstract][Full Text] [Related]
35. Endocannabinoid receptors gene expression in morbidly obese women with nonalcoholic fatty liver disease.
Auguet T; Berlanga A; Guiu-Jurado E; Terra X; Martinez S; Aguilar C; Filiu E; Alibalic A; Sabench F; Hernández M; Del Castillo D; Richart C
Biomed Res Int; 2014; 2014():502542. PubMed ID: 24864249
[TBL] [Abstract][Full Text] [Related]
36. Endocannabinoid system: An overview of its potential in current medical practice.
Mouslech Z; Valla V
Neuro Endocrinol Lett; 2009; 30(2):153-79. PubMed ID: 19675519
[TBL] [Abstract][Full Text] [Related]
37. Endocannabinoids and their role in fatty liver disease.
Mallat A; Lotersztajn S
Dig Dis; 2010; 28(1):261-6. PubMed ID: 20460921
[TBL] [Abstract][Full Text] [Related]
38. Cellular localization and regulation of receptors and enzymes of the endocannabinoid system in intestinal and systemic inflammation.
Grill M; Hasenoehrl C; Kienzl M; Kargl J; Schicho R
Histochem Cell Biol; 2019 Jan; 151(1):5-20. PubMed ID: 30196316
[TBL] [Abstract][Full Text] [Related]
39. Cannabinoid signaling and liver therapeutics.
Mallat A; Teixeira-Clerc F; Lotersztajn S
J Hepatol; 2013 Oct; 59(4):891-6. PubMed ID: 23567085
[TBL] [Abstract][Full Text] [Related]
40. The endocannabinoid system in inflammatory bowel diseases: from pathophysiology to therapeutic opportunity.
Alhouayek M; Muccioli GG
Trends Mol Med; 2012 Oct; 18(10):615-25. PubMed ID: 22917662
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
